In the early days of the H1N1 pandemic, when there was uncertainty about the infectivity and virulence of the new virus, a more precautionary approach to management was advocated. This included laboratory testing of suspected cases, contact tracing, isolation of cases and contacts, anti-viral medication for treatment and prophylaxis, and clinical surveillance and follow-up.